Groundbreaking scientists, led by Professor Shulamit Levenberg from the Technion and Prof. Danny Offen from Tel Aviv University, pioneered a revolutionary technology with the potential to drive recovery in individuals paralyzed by acute spinal cord trauma. “There is a possibility to give hope to many people who would otherwise be disabled,” say directors at NurExone Biologic, a company established to develop and commercialize this innovative technology.